Viral reverse transcriptases
|
journal
|
April 2017 |
Evolving understanding of HIV-1 reverse transcriptase structure, function, inhibition, and resistance
|
journal
|
April 2020 |
Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine
|
journal
|
February 2020 |
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1
|
journal
|
April 2013 |
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2
|
journal
|
April 2013 |
Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
|
journal
|
January 2009 |
Large-Scale Production and Structural and Biophysical Characterizations of the Human Hepatitis B Virus Polymerase
|
journal
|
March 2014 |
Molecular Modeling and Biochemical Characterization Reveal the Mechanism of Hepatitis B Virus Polymerase Resistance to Lamivudine (3TC) and Emtricitabine (FTC)
|
journal
|
May 2001 |
Discovery and Development of the Anti-Human Immunodeficiency Virus Drug, Emtricitabine (Emtriva, FTC)
|
journal
|
October 2016 |
Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes
|
journal
|
March 1992 |
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
|
journal
|
November 1992 |
Post-Catalytic Complexes with Emtricitabine or Stavudine and HIV-1 Reverse Transcriptase Reveal New Mechanistic Insights for Nucleotide Incorporation and Drug Resistance
|
journal
|
October 2020 |
Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV‐1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine
|
journal
|
August 2019 |
Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance
|
journal
|
December 2019 |
King of the pills
|
journal
|
May 2015 |
Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance
|
journal
|
October 2014 |
The Enantioselectivity of Enzymes Involved in Current Antiviral Therapy Using Nucleoside Analogues: A New Strategy?
|
journal
|
June 2000 |
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold
|
journal
|
June 2018 |
Structural basis for the D-stereoselectivity of human DNA polymerase β
|
journal
|
April 2017 |
Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ
|
journal
|
June 2015 |
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta -branched amino acids
|
journal
|
August 1999 |
Interactions of enantiomers of 2′,3′-didehydro-2′,3′-dideoxy-fluorocytidine with wild type and M184V mutant HIV-1 reverse transcriptase
|
journal
|
December 2002 |
Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
|
journal
|
October 2009 |
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
|
journal
|
January 2010 |
Nucleoside Analog Resistance Caused by Insertions in the Fingers of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involves ATP-Mediated Excision
|
journal
|
September 2002 |
Thymidine Analogue Resistance Suppression by V75I of HIV-1 Reverse Transcriptase
|
journal
|
November 2009 |
HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir
|
journal
|
January 2018 |
Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors
|
journal
|
February 2019 |
Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis—Binding of Foscarnet
|
journal
|
June 2016 |
Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer: Structure of RT Bound to 38-Mer DNA Aptamer
|
journal
|
September 2015 |
Structural Insights into HIV Reverse Transcriptase Mutations Q151M and Q151M Complex That Confer Multinucleoside Drug Resistance
|
journal
|
June 2017 |
Coupling Ribose Selection to Fidelity of DNA Synthesis
|
journal
|
June 2000 |
Conferring RNA polymerase Activity to a DNA polymerase: A single residue in reverse transcriptase controls substrate selection
|
journal
|
January 1997 |
Stereospecificity of human DNA polymerases α,β,γ,§ and ɛ, HIV-reverse transcriptase, HSV- DNA polymerase, calf thymus terminal transferase andEscherichia coliDNA polymerase I in recognizing D- and L-thymidine 5′-triphosphate as substrate
|
journal
|
January 1995 |
Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs
|
journal
|
February 1999 |
Stereoisomers of Deoxynucleoside 5′-Triphosphates as Substrates for Template-dependent and -independent DNA Polymerases
|
journal
|
April 1997 |
Chiral Discrimination of Enantiomeric 2′-Deoxythymidine 5′-Triphosphate by HIV-1 Reverse Transcriptase and Eukaryotic DNA Polymerases
|
journal
|
April 1994 |
Integrative structural biology studies of HIV-1 reverse transcriptase binding to a high-affinity DNA aptamer
|
journal
|
January 2020 |
Nucleotide-dependent conformational change governs specificity and analog discrimination by HIV reverse transcriptase
|
journal
|
April 2010 |
Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)
|
journal
|
August 2016 |
The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase
|
journal
|
October 2018 |
The Nucleoside Analogs 4′C-Methyl Thymidine and 4′C-Ethyl Thymidine Block DNA Synthesis by Wild-type HIV-1 RT and Excision Proficient NRTI Resistant RT Variants
|
journal
|
August 2007 |
Synthesis of new 2′-deoxy-2′-fluoro-4′-azido nucleoside analogues as potent anti-HIV agents
|
journal
|
September 2011 |
Effects of β-l-3′-azido-3′-deoxythymidine 5′-triphosphate on host and viral DNA polymerases
|
journal
|
August 2000 |
Antiviral l-Nucleosides Specific for Hepatitis B Virus Infection
|
journal
|
January 2001 |
Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3′-azido-2′,3′-dideoxypurine nucleosides
|
journal
|
September 2011 |
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
|
journal
|
May 2020 |
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
|
journal
|
December 2020 |
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
|
journal
|
February 2021 |
Inhibiting DNA Polymerases as a Therapeutic Intervention against Cancer
|
journal
|
November 2017 |
Pre-Steady-State Kinetic Analysis of the Incorporation of Anti-HIV Nucleotide Analogs Catalyzed by Human X- and Y-Family DNA Polymerases
|
journal
|
November 2010 |
Exploiting the Nucleotide Substrate Specificity of Repair DNA Polymerases To Develop Novel Anticancer Agents
|
journal
|
September 2011 |
Structural and kinetic insights into binding and incorporation of L-nucleotide analogs by a Y-family DNA polymerase
|
journal
|
August 2014 |
Innate immune driven evolution via immunostimulatory RNA: Viruses that mimic hosts, tumors that mimic viruses
|
journal
|
February 2017 |
Initial sequencing and analysis of the human genome
|
journal
|
February 2001 |
The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes
|
journal
|
April 2015 |
Silent pericentromeric repeats speak out
|
journal
|
November 2015 |
Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer
|
journal
|
November 2015 |
Phase II study of lamivudine in p53 mutant metastatic colorectal cancer (mCRC).
|
journal
|
February 2020 |
Telomerase and retrotransposons: Reverse transcriptases that shaped genomes
|
journal
|
December 2011 |
Measuring and interpreting transposable element expression
|
journal
|
June 2020 |
Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons
|
journal
|
August 2019 |
Inhibition of Telomerase Activity by Human Immunodeficiency Virus (HIV) Nucleos(t)ide Reverse Transcriptase Inhibitors: A Potential Factor Contributing to HIV-Associated Accelerated Aging
|
journal
|
January 2013 |
Repurposing anti-inflammasome NRTIs for improving insulin sensitivity and reducing type 2 diabetes development
|
journal
|
September 2020 |
Nucleoside reverse transcriptase inhibitors possess intrinsic anti-inflammatory activity
|
journal
|
November 2014 |
Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration
|
journal
|
February 2021 |
Nucleoside reverse transcriptase inhibitors and Kamuvudines inhibit amyloid-β induced retinal pigmented epithelium degeneration
|
journal
|
April 2021 |
Lamivudine InhibitsAluRNA-induced Retinal Pigment Epithelium Degeneration via Anti-inflammatory and Anti-senescence Activities
|
journal
|
July 2020 |
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
|
journal
|
July 2020 |
Compatibility and Fidelity of Mirror-Image Thymidine in Transcription Events by T7 RNA Polymerase
|
journal
|
September 2020 |